Cardiovascular Innovation Institute, University of Louisville, Louisville, Kentucky, USA.
Tissue Eng Part A. 2013 Jan;19(1-2):211-23. doi: 10.1089/ten.tea.2011.0408. Epub 2012 Sep 12.
The microvasculature is principally composed of two cell types: endothelium and mural support cells. Multiple sources are available for human endothelial cells (ECs) but sources for human microvascular mural cells (MCs) are limited. We derived multipotent mesenchymal progenitor cells from human embryonic stem cells (hES-MC) that can function as an MC and stabilize human EC networks in three-dimensional (3D) collagen-fibronectin culture by paracrine mechanisms. Here, we have investigated the basis for hES-MC-mediated stabilization and identified the pleiotropic growth factor hepatocyte growth factor/scatter factor (HGF/SF) as a putative hES-MC-derived regulator of EC network stabilization in 3D in vitro culture. Pharmacological inhibition of the HGF receptor (Met) (1 μm SU11274) inhibits EC network formation in the presence of hES-MC. hES-MC produce and release HGF while human umbilical vein endothelial cells (HUVEC) do not. When HUVEC are cultured alone the networks collapse, but in the presence of recombinant human HGF or conditioned media from human HGF-transduced cells significantly more networks persist. In addition, HUVEC transduced to constitutively express human HGF also form stable networks by autocrine mechanisms. By enzyme-linked immunosorbent assay, the coculture media were enriched in both angiopoietin-1 (Ang1) and angiopoietin-2 (Ang2), but at significantly different levels (Ang1=159±15 pg/mL vs. Ang2=30,867±2685 pg/mL) contributed by hES-MC and HUVEC, respectively. Although the coculture cells formed stabile network architectures, their morphology suggests the assembly of an immature plexus. When HUVEC and hES-MC were implanted subcutaneously in immune compromised Rag1 mice, hES-MC increased their contact with HUVEC along the axis of the vessel. This data suggests that HUVEC and hES-MC form an immature plexus mediated in part by HGF and angiopoietins that is capable of maturation under the correct environmental conditions (e.g., in vivo). Therefore, hES-MC can function as microvascular MCs and may be a useful cell source for testing EC-MC interactions.
内皮细胞和壁支持细胞。有多种来源可获得人内皮细胞(ECs),但人微血管壁细胞(MCs)的来源有限。我们从人胚胎干细胞(hES-MC)中获得多能间充质祖细胞,这些细胞可以作为 MC 发挥作用,并通过旁分泌机制稳定三维(3D)胶原-纤维连接蛋白培养中的人 EC 网络。在这里,我们研究了 hES-MC 介导的稳定化的基础,并确定了多效生长因子肝细胞生长因子/散射因子(HGF/SF)作为一种潜在的 hES-MC 来源的调节剂,可在 3D 体外培养中稳定 EC 网络。HGF 受体(Met)的药理学抑制(1μm SU11274)可抑制 hES-MC 存在时 EC 网络的形成。hES-MC 产生和释放 HGF,而人脐静脉内皮细胞(HUVEC)则不产生和释放 HGF。当 HUVEC 单独培养时,网络会崩溃,但在存在重组人 HGF 或经人 HGF 转导细胞的条件培养基时,显著更多的网络得以维持。此外,通过连续表达人 HGF 的 HUVEC 转导,也通过自分泌机制形成稳定的网络。通过酶联免疫吸附试验,共培养物中的血管生成素-1(Ang1)和血管生成素-2(Ang2)均丰富,但分别由 hES-MC 和 HUVEC 贡献的水平明显不同(Ang1=159±15pg/mL 与 Ang2=30,867±2685pg/mL)。尽管共培养细胞形成了稳定的网络结构,但它们的形态表明组装了一个不成熟的丛。当 HUVEC 和 hES-MC 被植入免疫缺陷 Rag1 小鼠的皮下时,hES-MC 增加了它们与 HUVEC 沿着血管轴的接触。这一数据表明,HUVEC 和 hES-MC 形成了一个不成熟的丛,部分由 HGF 和血管生成素介导,在正确的环境条件下(例如,体内)可以成熟。因此,hES-MC 可以作为微血管 MC 发挥作用,并且可能是测试 EC-MC 相互作用的有用细胞来源。